GOPC::ROS1 (6q22)

Genes involved

GOPC (6q22.1)

ROS1 (6q22.1)

Oncogenic mechanisms

Constitutive activation of ROS1 tyrosine kinase activity

Targeted therapy

Crizotinib

Entrectinib

Tumor type

Lung adenocarcinoma

Glioma

Highly cited references

Pubmed IDYearTitleCitations
221630032011Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.78
348751332022Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.61
381952202025Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients.59
375377832023Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.58
319956212020Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.52
301710482018Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.51
360538342022ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer.50
382548502024Translation into Clinical Practice of the G1-G7 Molecular Subgroup Classification of Glioblastoma: Comprehensive Demographic and Molecular Pathway Profiling.46
230522552012Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.38
345992622021Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer.35
289121532017Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.33
370758102023LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.32
388456902024Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion.25
326527532020Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report.24
340766662021Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.16
345361222021GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.11
337333422021GOPC-ROS1 mosaicism in agminated Spitz naevi: report of two cases.0
249992092014Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomas.0
316262892019GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.0
319293842020Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case.0
375321822023ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.0
299358462018GOPC-ROS1 Rearrangement as an Acquired Resistance Mechanism to Osimertinib and Responding to Crizotinib Combined Treatments in Lung Adenocarcinoma.0
367074252023Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma.0
351724822017Acral Lentiginous Melanoma Harboring a ROS1 Gene Fusion With Clinical Response to Entrectinib.0
288441732017Clinical Application of Whole Genome Array Improves the Diagnosis of Pediatric Brain Tumors.0

Bibliography

Pubmed IDPublication YearTitleAuthors
230522552012Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.Suehara Y, et al
238774382013CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma.Matsuura S, et al
283876432017Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor.Kiehna EN, et al